Work

Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies

Year: 2016

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2015.12.851

Authors: Mark R. Stein, Richard L. Wasserman, Isaac Melamed, Sudhir Gupta, Lisa J. Kobrynski, Arye Rubinstein, Christopher J. Rabbat, Werner Engl, Barbara McCoy, Heinz Leibl, Leman Yel

Institutions: Allergy Associates of the Palm Beaches, IMMUNOe Research Center, University of California, Irvine, Emory University, Albert Einstein College of Medicine, Baxalta (United States)

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2337764788

FWCI:

Cites:

Cited by: 1

Related to: 10